Total Cost of Care Will Define Value Propositions

As they move increasingly toward a value-based model, health care systems are also being expected to take on more risk, so every contributor to the total cost of care will increasingly be scrutinized in terms of the value that it brings. Now, life science business leaders have an unrivalled opportunity to learn from senior clinicians and healthcare administrators exactly how these latest trends in the US healthcare landscape are set to impact their commercial organizations. During an extensive live Q&A session on Friday, February 12, three senior healthcare experts will provide privileged insight into “How 2016 Healthcare Trends will Shape Market Access Strategies” as part of an expert roundtable with CMR Institute. Taking place at 12 noon ET, this live webinar will offer participants the opportunity to put their questions to: Dr Jeffrey Farber, CEO, Mount Sinai Care; Denise Prince, CEO, Keystone ACO; and Gary Rice, Senior Vice President, Clinical, Education and Human Resources, Diplomat Specialty Pharmacy. New payment model Dr Farber, who runs a Medicare shared savings program ACO (accountable care organization), sums up the current US healthcare landscape: “The market is moving very rapidly in what I believe is a major transformation from a fee-for-service model that has dominated the landscape for the past 40-50 years to a real change to fee for value. The purchasers – the ones that are paying over $3 trillion a year in healthcare services in this country –...
Source: EyeForPharma - Category: Pharmaceuticals Authors: Source Type: news